- Telehealth Visits
Jeffrey Ni, MD
Pediatric PulmonologyOn this page
About me
Dr. Jeff Ni is a pediatric pulmonologist, a specialist in caring for young patients with respiratory conditions. He is particularly interested in treating those with asthma, bronchopulmonary dysplasia, bronchiectasis, and pulmonary complications from sickle cell disease, as well as patients who need a tracheostomy or ventilator to breathe.
Ni has conducted research exploring the development of pulmonary hypertension (high blood pressure in the lungs).
Ni earned his medical degree from Loyola University Chicago Stritch School of Medicine. He completed a residency in pediatrics at the University of Chicago and a fellowship in pediatric pulmonology at Stanford University.
Ni is a member of the American Thoracic Society (ATS) and the American Academy of Pediatrics (AAP). In addition to a resident of the year award from the University of Chicago, he has also earned honors for his research, including a Lightning Talk award at Stanford and both a Whitsett Award and an abstract scholarship from the ATS.
Education
Board Certification
- Pediatrics, American Board of Pediatrics
Residency
- Pediatrics, University of Chicago
School
- MD, Loyola University Of Chicago Stritch School Of Medicine
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Pediatric Pulmonology
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%225523%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225523%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.